Delivery Order SPE2DB22D1202-SPE2DB24FVND5
Award Date
9/10/24
Potential Completion Date
10/1/24
Potential Value
$8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,978.09, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a leading global pharmaceutical distribution company, to provide TESTOPEL 75 MG PELLETS 100S medication. This is a firm fixed price delivery order contract with an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corporation, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as the prime...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,115.58, is for the delivery of TESTOPEL 75 MG PELLETS 100S, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 7, 2025. This award is not associated with a set-aside program and appears to be...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,978.09 fixed-price delivery order is for the supply of TESTOPEL 75 MG PELLETS 100S, a medical product, with a completion date of November 25, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $3,978.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564594203 - TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product. The contract does not have a set-aside designation and is a Delivery Order with a Firm Fixed Price pricing type. It has an ultimate completion date of May 31, 2024. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product, with a ceiling value of $11,934.27. The contract is a firm fixed-price delivery order and does not have a set-aside designation. AmerisourceBergen is the prime contractor, and the contract has an ultimate completion date of September 13, 2024. This...
This is a $3,978.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,289,653 units of TESTOPEL 75 MG PELLETS 100S. The award is not associated with a set-aside program. Amerisourcebergen, through its Corporate Office division, provides a wide range of pharmaceutical and medical products to various government agencies, including the military, under multiple indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 100 units of TESTOPEL 75 MG PELLETS. The $3,978.09 contract has a completion date of March 26, 2024. AmerisourceBergen Drug Corp is the prime contractor and a for-profit organization. This award is issued under an indefinite delivery contract (IDC) with DLA, with a potential value of $999,999,999.00 and a performance period...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $7,956.18 firm fixed price delivery order is for the supply of 100 units of the medication TESTOPEL 75 MG PELLETS. This contract award is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,978.09 contract is for the supply of TESTOPEL 75 MG PELLETS 100S, a medical product, with a period of performance through August 13, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,978.09 and is for the delivery of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...